BeOne Medicines
ONC
#542
Rank
โ‚ฌ41.66 B
Marketcap
364,76ย โ‚ฌ
Share price
5.09%
Change (1 day)
28.05%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2023 (TTM): -15,89ย โ‚ฌ

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is 5,36ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -17,36ย โ‚ฌ a decrease over its 2021 EPS that were of -13,63ย โ‚ฌ.

EPS history for BeOne Medicines from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-15,89ย โ‚ฌ-8.46%
2022-17,36ย โ‚ฌ27.35%
2021-13,63ย โ‚ฌ-19.96%
2020-17,03ย โ‚ฌ20.81%
2019-14,10ย โ‚ฌ31.52%
2018-10,72ย โ‚ฌ417.57%
2017-2,07ย โ‚ฌ-37.16%
2016-3,30ย โ‚ฌ158.95%
2015-1,27ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-0,08067ย โ‚ฌ-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0,85ย โ‚ฌ-115.89%๐Ÿ‡บ๐Ÿ‡ธ USA